Fredun Pharmaceuticals Ltd
539730NSE
₹0.00▲ +0.00 (+0.00%)
Mkt cap₹2,470 Cr
P/E100.39
Volume—
Day range—
52W range1,400 – 1,590
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
Fredun Pharmaceuticals Ltd (539730): company summary
Fredun Pharmaceuticals Ltd (539730) is a micro-cap Healthcare company valued at ₹2,470 crore operating in Pharmaceuticals on the NSE and BSE.
Fredun Pharmaceuticals Ltd (539730) is a micro-cap Healthcare company valued at ₹2,470 crore operating in Pharmaceuticals on the NSE and BSE.
- Financial performance
- Revenue has been growing strongly at 32.5% a year over three years; profit grew 43.6% a year, ahead of revenue — margins are expanding. Return on equity is 15.8%.
- Valuation multiples
- The stock trades at 100.4 times earnings, a premium to the Healthcare median of 32.0, 9.14 times book value. It yields 0.1%.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
52W₹1400
₹1590
Key numbers
Price-based figures are live; statement figures are from FY26, consolidated where filed.
Valuation
- Market cap
- ₹2,470 Cr
- P/E
- 100.4×
- P/B
- 9.1×
- P/S
- —
- EV/EBITDA
- —
- Earnings yield
- 1.0%
- Dividend yield
- 0.05%
- Fair value
Profitability
- ROE
- 15.8%
- ROCE
- 19.0%
- ROIC
- —
- ROA
- —
- Gross margin
- —
- Operating margin
- 12.0%
- Net margin
- 4.6%
- EPS (TTM/FY)
- ₹14.65
Growth
- Sales · last qtr YoY
- —
- Profit · last qtr YoY
- —
- Sales · 1Y
- —
- Profit · 1Y
- —
- Sales CAGR · 3Y / 5Y
- +32% / +37%
- Profit CAGR · 3Y / 5Y
- +44% / +75%
- EPS CAGR · 5Y
- +65%
- Sales CAGR · 10Y
- +31%
Balance sheet
- Debt / equity
- 0.80
- Net debt / EBITDA
- —
- Interest cover
- —
- Current ratio
- —
- Total debt
- ₹222 Cr
- Cash
- —
- Book value / share
- ₹162.8
- Free cash flow
- −₹57 Cr
Quality & trading
- Piotroski F-score
- —
- Altman Z
- —
- Cash conversion cycle
- 201 days
- Dividend payout
- 1%
- Delivery %
- —
- Volume vs 30D avg
- —
- Avg traded value
- —
- Face value
- ₹10.00
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Fredun Pharmaceuticals Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Fredun Pharmaceuticals Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedLaurus Labs LimitedZydus Lifesciences LimitedApollo Hospitals Enterprise LimitedDr. Reddy's Laboratories LimitedCipla LimitedMankind Pharma LimitedAurobindo Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Fredun Pharmaceuticals Ltd with peers
Fredun Pharmaceuticals Ltd vs Sun Pharmaceutical Industries LimitedFredun Pharmaceuticals Ltd vs Divi's Laboratories LimitedFredun Pharmaceuticals Ltd vs Torrent Pharmaceuticals LimitedFredun Pharmaceuticals Ltd vs Laurus Labs LimitedFredun Pharmaceuticals Ltd vs Zydus Lifesciences LimitedFredun Pharmaceuticals Ltd vs Apollo Hospitals Enterprise Limited
Related tools & concepts
Value Fredun Pharmaceuticals Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing